Advertisement

Human Genetics

, Volume 78, Issue 2, pp 151–155 | Cite as

The CpG dinucleotide and human genetic disease

  • David N. Cooper
  • Hagop Youssoufian
Original Investigations

Summary

Reports of single base-pair mutations within gene coding regions causing human genetic disease were collated. Thirty-five per cent of mutations were found to have occurred within CpG dinucleotides. Over 90% of these mutations were C → T or G → A transitions, which thus occur within coding regions at a frequency 42-fold higher than that predicted from random mutation. These findings are consistent with methylation-induced deamination of 5-methyl cytosine and suggest that methylation of DNA within coding regions may contribute significantly to the incidence of human genetic disease.

Keywords

Internal Medicine Metabolic Disease Genetic Disease Cytosine Code Region 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Antonarakis SE, Kazazian H, Orkin SH (1985a) DNA polymorphism and molecular pathology of the human globin gene clusters. Hum Genet 69:1–14Google Scholar
  2. Antonarakis SE, Waber PG, Kittur SD, Patel AS, Kazazian HH, Mellis MA, Counts RB, Stamatoyannopoulos G, Bowie W, Fass DN, Pittman DD, Wozney JM, Toole JJ (1985b) Hemophila A; detection of molecular defects and of carriers by DNA analysis. N Engl J Med 313:842–848Google Scholar
  3. Antonarakis SE, Youssoufian H, Kazazian HH (1987) Molecular genetics of hemophilia A in man (factor VIII deficiency). Mol Biol Med 4:81–84Google Scholar
  4. Barker D, Schäfer M, White R (1984) Restriction sites containing CpG show a higher frequency of polymorphism in human DNA. Cell 36:131–138Google Scholar
  5. Bentley AK, Rees DJG, Rizza C, Brownlee GG (1986) Defective propeptide processing of blood clotting factor IX caused by mutation of arginine to glutamine at position-4. Cell 45:343–348Google Scholar
  6. Bird AP (1980) DNA methylation and the frequency of CpG in animal DNA. Nucleic Acids Res 8:1499–1504Google Scholar
  7. Bird AP (1986) CpG-rich islands and the function of DNA methylation. Nature 321:209–213Google Scholar
  8. Bird A, Taggart M, Frommer M, Miller OJ, Macleod D (1985) A fraction of the mouse genome that is derived from islands of nonmethylated, CpG-rich DNA. Cell 40:91–99Google Scholar
  9. Bird AP, Taggart MH, Nichols RD, Higgs DR (1987) Non-methylated CpG-rich islands at the human α-globin locus: implications for evolution of the α-globin pseudogene. EMBO J 6:999–1004Google Scholar
  10. Bonthron DT, Markham AF, Ginsburg D, Orkin SH (1985) Identification of a point mutation in the adenosine deaminase gene responsible for immunodeficiency. J Clin Invest 76:894–897Google Scholar
  11. Brown WRA, Bird AP (1986) Long-range restriction site mapping of mammalian genomic DNA. Nature 322:477–481Google Scholar
  12. Bullock E, Elton RA (1972) Dipeptide frequencies in proteins and the CpG deficiency in vertebrate DNA. J Mol Evol 1:315–325Google Scholar
  13. Chan SJ, Seino S, Gruppuso PA, Schwartz R, Steiner DF (1987) A mutation in the β chain coding region is associated with impaired proinsulin conversion in a family with hyperproinsulinaemia. Proc Natl Acad Sci USA 84:2194–2197Google Scholar
  14. Cladaras C, Hadzopoulou-Cladaras M, Felber BK, Pavlakis G, Zannis VI (1987) The molecular basis of a familial Apo E deficiency. J Biol Chem 262:2310–2315Google Scholar
  15. Cohn DH, Byers PH, Steinman B, Gelinas RE (1986) Lethal osteogenesis imperfecta resulting from a single nucleotide change in one human pro α1 (I) collagen allele. Proc Natl Acad Sci USA 83:6045–6047Google Scholar
  16. Cooper DN (1983) Eukaryotic DNA methylation. Hum Genet 64:315–333Google Scholar
  17. Cooper DN, Gerber-Huber S (1985) DNA methylation and CpG suppression. Cell Differ 17:199–205Google Scholar
  18. Cooper DN, Schmidtke J (1984) DNA restriction fragment length polymorphisms and heterozygosity in the human genome. Hum Genet 66:1–16Google Scholar
  19. Cooper DN, Schmidtke J (1986) Diagnosis of genetic disease using recombinant DNA. Hum Genet 73:1–11Google Scholar
  20. Cooper DN, Schmidtke J (1987) Diagnosis of genetic disease using recombinant DNA. Supplement. Hum Genet 77:66–75Google Scholar
  21. Cooper DN, Taggart MH, Bird AP (1983) Unmethylated domains in vertebrate DNA. Nucleic Acids Res 11:647–658Google Scholar
  22. Cooper DN, Smith BA, Cooke HJ, Niemann S, Schmidtke J (1985) An estimate of unique DNA sequence heterozygosity in the human genome. Hum Genet 69:201–205Google Scholar
  23. Cooper DN, Gerber-Huber S, Nardelli D, Schubiger J-L, Wahli W (1987) The distribution of the dinucleotide CpG and cytosine methylation in the vitellogenin gene family. J Mol Evol 25:107–115Google Scholar
  24. Coulondre C, Miller JH, Farabaugh PJ, Gilbert W (1978) Molecular basis of base substitution hotspots in Escherichia coli. Nature 274:775–780Google Scholar
  25. Daar IO, Artymiuk PJ, Phillips DC, Maquat LE (1986) Human triose-phosphate isomerase deficiency: a single amino acid substitution results in a thermolabile enzyme. Proc Natl Acad Sci USA 83:7903–7907Google Scholar
  26. Davis LM, McGraw RA, Ware JL, Roberts HR, Stafford DW (1987) Factor IX alabama: a point mutation in a clotting protein results in hemophilia B. Blood 69:140–143Google Scholar
  27. De Verneuil H, Grandchamp B, Beaumont C, Picat C, Nordmann Y (1986) Uroporphyrinogen decarboxylase structural mutant (Gly281 → Glu) in a case of porphyria. Science 234:732–734Google Scholar
  28. DiLella AG, Marvit J, Lidsky AS, Guttler F, Woo SLC (1986) Tight linkage between a splicing mutation and a specific DNA haplotype in phenylketonuria. Nature 322:799–803Google Scholar
  29. DiLella AG, Marvit J, Brayton K, Woo SLC (1987) An amino-acid substitution involved in phenylketonuria is in linkage disequilibrium with DNA haplotype 2. Nature 327:333–336Google Scholar
  30. Duchange N, Chassé J-F, Cohen GN, Zakin NM (1986) Antithrombin III Tours gene: identification of a point mutation leading to an arginine → cysteine replacement in a silent deficiency. Nucleic Acids Res 14:2408Google Scholar
  31. Gardiner-Garden M, Frommer M (1987) CpG islands in vertebrate genomes. J Mol Biol 196:261–282Google Scholar
  32. Gitschier J, Wood WL, Tuddenham EGD, Shuman MA, Goralka TM, Chen EY, Lawn RM (1985) Detection and sequence of mutations in the factor VIII gene of haemophiliacs. Nature 315:427–430Google Scholar
  33. Gitschier J, Wood WI, Shuman MA, Lawn RM (1986) Identification of a missense mutation in the factor VIII gene of a mild hemophiliac. Science 232:1415–1416Google Scholar
  34. Grippo P, Iaccarino M, Parisi E, Scarano E (1968) Methylation of DNA in developing sea urchin embryos. J Mol Biol 36:195–208Google Scholar
  35. Haneda M, Chan SJ, Kwok SCM, Rubenstein AH, Steiner DF (1983) Studies on mutant human insulin genes: identification and sequence analysis of a gene encoding [Ser B24] insulin. Proc Natl Acad Sci USA 80:6366–6370Google Scholar
  36. Josse J, Kaiser AD, Kornberg A (1961) Enzymatic synthesis of deoxyribonucleic acid. VIII. Frequencies of nearest neightbor base sequences in deoxyribonucleic acid. J Biol Chem 236:864–875Google Scholar
  37. Keshet I, Lieman-Hurwitz J, Cedar H (1986) DNA methylation affects the formation of active chromatin. Cell 44:535–543Google Scholar
  38. Kidd VJ, Wallace RB, Itakura K, Woo SLC (1983) 155-1 deficiency detection by direct analysis of the mutation in the gene. Nature 304:230–234Google Scholar
  39. Law SW, Brewer HB (1985) Tangier disease: the complete mRNA sequence encoding for preproapo-A1. J Biol Chem 260:12810–12814Google Scholar
  40. Lehrman MA, Goldstein JL, Brown MS, Russell DW, Schneider WJ (1985) Internalization-defective LDL receptors produced by genes with nonsense and frameshift mutations that truncate the cytoplasmic domain. Cell 41:735–743Google Scholar
  41. Li Q, Powers PA, Smithies O (1985) Nucleotide sequence of 16 kilobase pairs of DNA 5′ to the human ɛ-globin gene. J Biol Chem 260:14901–14910Google Scholar
  42. Lindsay S, Bird AP (1987) Use of restriction enzymes to detect potential gene sequences in mammalian DNA. Nature 327:336–338Google Scholar
  43. Long I (1987) Structure and evolution of the human genes encoding protein C and coagulation factor IX. J Cell Biochem 33:185–190Google Scholar
  44. Maeda S, Mita S, Araki S, Shimada K (1986) Structure and expression of the mutant prealbumin gene associated with familial amyloidotic polyneuropathy. Mol Biol Med 3:329–338Google Scholar
  45. Nukiwa T, Satoh K, Brantly ML, Ogushi F, Fells GA, Courtney M, Crystal RG (1986) Identification of a second mutation in the protein-coding sequence of the Z type alpha 1-anti-trypsin gene. J Biol Chem 261:15989–15994Google Scholar
  46. Nussinov R (1981) Eukaryotic dinucleotide preference rules and their implications for degenerate codon usage. J Mol Biol 149:125–131Google Scholar
  47. Razin A, Szyf M (1984) DNA methylation patterns: formation and function. Biochim Biophys Acta 782:331–342Google Scholar
  48. Rees DJG, Rizza CR, Brownlee GG (1985) Haemophilia B caused by a point mutation in a donor splice junction of the human factor IX gene. Nature 316:643–645Google Scholar
  49. Romeo G, Hassan HJ, Staempfli S, Roncuzzi L, Cianetti L, Leonardi A, Vincente V, Mannucci PM, Bertina R, Peschle C, Cortese R (1987) Hereditary thrombophilia: identification of nonsense and missense mutations in the protein C gene. Proc Natl Acad Sci USA 84:2829–2832Google Scholar
  50. Savatier P, Trabuchet G, Fauré C, Chebloure Y, Gouy M, Verdier G, Nigon VM (1985) Evolution of the primate beta-globin gene region. High rate of variation in CpG dinucleotides and in short repeated sequences between man and chimpanzee. J Mol Biol 182:21–29Google Scholar
  51. Selker EV, Stevens JN (1985) DNA methylation at asymetric sites is associated with numerous transition mutations. Proc Natl Acad Sci USA 82:8114–8118Google Scholar
  52. Shibasaki Y, Kawakami T, Kanazawa Y, Akanuma Y, Takaku F (1985) Post-translational cleavage of proinsulin is blocked by a point mutation in familial hyperproinsulinemia. J Clin Invest 76:378–380Google Scholar
  53. Shoelson S, Haneda M, Blix P, Nanjo A, Sanke T, Inouye K, Steiner D, Rubenstein A, Tager H (1983) Three mutant insulins in man. Nature 302:540–543Google Scholar
  54. Stavnezer-Nordgren J, Kekish O, Zegers BJM (1985) Molecular defects in a human immunoglobulin K chain deficiency. Science 230:458–461Google Scholar
  55. Tsuji S, Choudary PV, Martin BM, Stubblefield BK, Mayor JA, Barranger JA, Ginns EI (1987) A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease. N Engl J Med 316:570–575Google Scholar
  56. Valerio D, Dekker BMM, Duyvesteyn MGC, Voorn L van der, Berkvens TM, Ormondt H van, Eb AJ van der (1986) One adenosine deaminase allele in a patient with severe combined immunodeficiency contains a point mutation abolishing enzyme activity. EMBO J 5:113–119Google Scholar
  57. Vogel F, Kopun M (1977) Higher frequencies of transitions among point mutations. J Mol Evol 9:159–180Google Scholar
  58. Wallace MR, Dwulet FE, Conneally PM, Benson MD (1986) Biochemical and molecular genetic characterization of a new variant prealbumin associated with hereditary amyloidosis. J Clin Invest 78:6–12Google Scholar
  59. Wang RY-H, Kuo KC, Gehrke CW, Huang L-H, Ehrich M (1982) Heat and alkali-induced deamination of 5-methylcytosine and cytosine residues in DNA. Biochim Biophys Acta 697:371–377Google Scholar
  60. Williams SR, Gekeler V, Mclvor RS, Martin DW (1987) A human purine nucleoside phosphorylase deficiency caused by a single base change. J Biol Chem 262:2332–2338Google Scholar
  61. Youssoufian H, Kazazian HH, Phillips DG, Aronis S, Tsiftis G, Brown VA, Antonarakis SE (1986) Recurrent mutations in haemophilia A give evidence for CpG mutation hotspots. Nature 324:380–382Google Scholar

Copyright information

© Springer-Verlag 1988

Authors and Affiliations

  • David N. Cooper
    • 1
  • Hagop Youssoufian
    • 2
  1. 1.Haematology DepartmentKing's College School of Medicine and DentistryLondonUK
  2. 2.Genetics Unit, Department of PediatricsThe Johns Hopkins University School of MedicineBaltimoreUSA

Personalised recommendations